Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging

被引:17
|
作者
Giacomucci, G. [1 ]
Monforte, M. [2 ]
Diaz-Manera, J. [3 ,4 ]
Mul, K. [5 ]
Torron, R. Fernandez [6 ,7 ]
Maggi, L. [8 ]
Bettolo, C. Marini [6 ]
Dahlqvist, J. R. [9 ]
Haberlova, J. [10 ,11 ]
Camano, P. [12 ,13 ]
Gros, M. [14 ,15 ]
Tartaglione, T. [16 ]
Cristiano, L. [16 ]
Gerevini, S. [17 ]
Calandra, P. [18 ]
Deidda, G. [18 ]
Giardina, E. [19 ]
Sacconi, S. [14 ,15 ]
Straub, V [6 ]
Vissing, J. [9 ]
Van Engelen, B. [5 ]
Ricci, E. [1 ,2 ]
Tasca, G. [2 ]
机构
[1] Univ Cattolica Sacro Cuore, Ist Neurol, Rome, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Unita Operat Complessa Neurol, Rome, Italy
[3] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, Neuromuscular Disorders Unit, Barcelona, Spain
[4] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain
[5] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Neurol, Med Ctr, Nijmegen, Netherlands
[6] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England
[7] Hosp Donostia, Biodonostia Hlth Res Inst, Neurol Dept, Basque Hlth Serv,Neuromuscular Area, Donostia San Sebastian, Spain
[8] Fdn IRCCS Ist Neurol Carlo Besta, Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy
[9] Copenhagen Univ Hosp, Rigshosp, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark
[10] Charles Univ Prague, Fac Med 2, Dept Pediat Neurol, Prague, Czech Republic
[11] Univ Hosp Moto, Prague, Czech Republic
[12] Grp Neuromuscular Dis, Neurosci Area, Biodonostia, San Sebastian, Spain
[13] Biodonostia Osakidetza Basque Hlth Serv, Mol Diagnost Platform, San Sebastian, Spain
[14] Univ Cote Azur UCA, Muscle & ALS Dept, Pasteur Hosp 2, Peripheral Nervous Syst, Nice, France
[15] Univ Cote Azur, Inst Res Canc & Aging Nice IRCAN, CNRS, INSERM, Nice, France
[16] Ist Dermopat Immacolata IRCCS FLMM, Radiol Unit, Rome, Italy
[17] IRCCS San Raffaele Hosp, Neuroradiol Dept, Milan, Italy
[18] Natl Res Council Italy, Inst Cell Biol & Neurobiol, Rome, Italy
[19] Univ Roma Tor Vergata, Mol Genet Lab UILDM, Santa Lucia Fdn IRCSS, Rome, Italy
基金
欧盟地平线“2020”;
关键词
facioscapulohumeral muscular dystrophy; FSHD; FSHD2; muscle MRI; neuromuscular diseases; MUSCLE INVOLVEMENT; DISEASE SEVERITY; SMCHD1; MRI; MUTATIONS; GENE; D4Z4; VARIABILITY; METHYLATION; FEATURES;
D O I
10.1111/ene.14446
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data. Methods Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1-weighted and short-tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema. Results The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro-caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2. Conclusion This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD-related disease spectrum.
引用
收藏
页码:2604 / 2615
页数:12
相关论文
共 50 条
  • [21] Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study
    Blaszczyk, Edyta
    Lim, Carolin
    Kellman, Peter
    Schmacht, Luisa
    Groschel, Jan
    Spuler, Simone
    Schulz-Menger, Jeanette
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2021, 23 (01)
  • [22] Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study
    Edyta Blaszczyk
    Carolin Lim
    Peter Kellman
    Luisa Schmacht
    Jan Gröschel
    Simone Spuler
    Jeanette Schulz-Menger
    Journal of Cardiovascular Magnetic Resonance, 23
  • [23] Facioscapulohumeral muscular dystrophy type 1 combined with becker muscular dystrophy: a family case report
    Tan, Menglin
    Huo, Huiyi
    Feng, Jieming
    Wang, Chandi
    Jiang, Suhua
    FRONTIERS IN GENETICS, 2025, 15
  • [24] Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy
    Mankodi, Ami
    Kovacs, William
    Norato, Gina
    Hsieh, Nathan
    Bandettini, W. Patricia
    Bishop, Courtney A.
    Shimellis, Hirity
    Newbould, Rexford D.
    Kim, Eunhee
    Fischbeck, Kenneth H.
    Arai, Andrew E.
    Yao, Jianhua
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (09): : 655 - 662
  • [25] Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy
    Kashyap, Niharika
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (24):
  • [26] Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy
    Kashyap, Niharika
    Nikhanj, Anish
    Labib, Dina
    Prosia, Easter
    Rivest, Sandra
    Flewitt, Jacqueline
    Pfeffer, Gerald
    Bakal, Jeffrey A.
    Siddiqi, Zaeem A.
    Coulden, Richard A.
    Thompson, Richard
    White, James A.
    Oudit, Gavin Y.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (21):
  • [27] Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings
    Jia, Fangzhi Frank
    Drew, Alexander P.
    Nicholson, Garth Alexander
    Corbett, Alastair
    Kumar, Kishore Raj
    NEUROMUSCULAR DISORDERS, 2021, 31 (11) : 1101 - 1112
  • [28] Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1
    Lareau-Trudel, Emilie
    Le Troter, Arnaud
    Ghattas, Badih
    Pouget, Jean
    Attarian, Shahram
    Bendahan, David
    Salort-Campana, Emmanuelle
    PLOS ONE, 2015, 10 (07):
  • [29] Muscle magnetic resonance imaging in patients with LAMA2-related muscular dystrophy
    Tan, Dandan
    Ge, Lin
    Fan, Yanbin
    Wei, Cuijie
    Yang, Haipo
    Liu, Aijie
    Xiao, Jiangxi
    Xiong, Hui
    Zhu, Ying
    NEUROMUSCULAR DISORDERS, 2021, 31 (11) : 1144 - 1153
  • [30] Two Cases of Facioscapulohumeral Muscular Dystrophy 2 in Korea
    Lee, Jung Hwan
    Park, Hyung Jun
    Seong, Moon-Woo
    Park, Sung Sup
    Choi, Young-Chul
    YONSEI MEDICAL JOURNAL, 2021, 62 (01) : 95 - 98